Literature DB >> 20580332

Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the "Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease.

Domenico Alvaro1, Maria Consiglia Bragazzi, Antonio Benedetti, Luca Fabris, Giammarco Fava, Pietro Invernizzi, Marco Marzioni, Gennaro Nuzzo, Mario Strazzabosco, Tommaso Stroffolini.   

Abstract

BACKGROUND: Very few studies assessed cholangiocarcinoma clinical characteristics. AIM: To evaluate the clinical characteristics of intra-hepatic (IH) and extra-hepatic (EH)-CCA.
METHODS: We performed a national survey based on a questionnaire.
RESULTS: 218 cholangiocarcinomas were observed (47% EH-CCA, 53% IH-CCA) with an age at the diagnosis higher for EH-CCA. Coexistence of cirrhosis or viral cirrhosis was more frequent in IH-CCA than EH-CCA. An incidental asymptomatic presentation occurred in 28% of IH-CCA vs 4% EH-CCA whilst, 74% EH-CCA vs 28% IH-CCA presented with jaundice. 91% of IH-CCA presented as a single intra-hepatic mass, whilst 50% of EH-CCA was peri-hilar. In the diagnostic work-up, 70% of all cholangiocarcinoma cases received at least 3 different imaging procedures. Tissue-proven diagnosis was obtained in 80% cholangiocarcinoma. Open surgery with curative intent was performed in 45% of IH-CCA and 29% EH-CCA. 18% IH-CCA vs 4% EH-CCA did not received treatment.
CONCLUSIONS: In Italy IH-CCA is managed as frequently as EH-CCA. In comparison to EH-CCA, IH-CCA occurs at younger age and is more frequently associated with cirrhosis and with an incidental asymptomatic presentation. In contrast, most EH-CCAs are jaundiced at the diagnosis. Cholangiocarcinoma diagnostic management is cost- and time-consuming with curative surgical treatment applicable more frequently in IH-CCA.
Copyright © 2010 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20580332     DOI: 10.1016/j.dld.2010.05.002

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  18 in total

Review 1.  Cholangiocarcinoma 2020: the next horizon in mechanisms and management.

Authors:  Jesus M Banales; Jose J G Marin; Angela Lamarca; Pedro M Rodrigues; Shahid A Khan; Lewis R Roberts; Vincenzo Cardinale; Guido Carpino; Jesper B Andersen; Chiara Braconi; Diego F Calvisi; Maria J Perugorria; Luca Fabris; Luke Boulter; Rocio I R Macias; Eugenio Gaudio; Domenico Alvaro; Sergio A Gradilone; Mario Strazzabosco; Marco Marzioni; Cédric Coulouarn; Laura Fouassier; Chiara Raggi; Pietro Invernizzi; Joachim C Mertens; Anja Moncsek; Sumera Rizvi; Julie Heimbach; Bas Groot Koerkamp; Jordi Bruix; Alejandro Forner; John Bridgewater; Juan W Valle; Gregory J Gores
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-06-30       Impact factor: 46.802

Review 2.  Cholangiocarcinoma: increasing burden of classifications.

Authors:  Vincenzo Cardinale; Maria Consiglia Bragazzi; Guido Carpino; Alessia Torrice; Alice Fraveto; Raffaele Gentile; Vincenzo Pasqualino; Fabio Melandro; Camilla Aliberti; Carlo Bastianelli; Roberto Brunelli; Pasquale Bartolomeo Berloco; Eugenio Gaudio; Domenico Alvaro
Journal:  Hepatobiliary Surg Nutr       Date:  2013-10       Impact factor: 7.293

Review 3.  Preneoplastic conditions underlying bile duct cancer.

Authors:  Lena Sibulesky; Justin Nguyen; Tushar Patel
Journal:  Langenbecks Arch Surg       Date:  2012-03-06       Impact factor: 3.445

4.  Intra-hepatic and extra-hepatic cholangiocarcinoma: New insight into epidemiology and risk factors.

Authors:  Vincenzo Cardinale; Rossella Semeraro; Alessia Torrice; Manuela Gatto; Cristina Napoli; Maria Consiglia Bragazzi; Raffaele Gentile; Domenico Alvaro
Journal:  World J Gastrointest Oncol       Date:  2010-11-15

5.  Melatonin exerts by an autocrine loop antiproliferative effects in cholangiocarcinoma: its synthesis is reduced favoring cholangiocarcinoma growth.

Authors:  Yuyan Han; Sharon Demorrow; Pietro Invernizzi; Qing Jing; Shannon Glaser; Anastasia Renzi; Fanyin Meng; Julie Venter; Francesca Bernuzzi; Mellanie White; Heather Francis; Ana Lleo; Marco Marzioni; Paolo Onori; Domenico Alvaro; Guido Torzilli; Eugenio Gaudio; Gianfranco Alpini
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-07-21       Impact factor: 4.052

6.  Oncogenic role of the Notch pathway in primary liver cancer.

Authors:  Jie Lu; Yujing Xia; Kan Chen; Yuanyuan Zheng; Jianrong Wang; Wenxia Lu; Qin Yin; Fan Wang; Yingqun Zhou; Chuanyong Guo
Journal:  Oncol Lett       Date:  2016-05-18       Impact factor: 2.967

7.  Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).

Authors:  Jesus M Banales; Vincenzo Cardinale; Guido Carpino; Marco Marzioni; Jesper B Andersen; Pietro Invernizzi; Guro E Lind; Trine Folseraas; Stuart J Forbes; Laura Fouassier; Andreas Geier; Diego F Calvisi; Joachim C Mertens; Michael Trauner; Antonio Benedetti; Luca Maroni; Javier Vaquero; Rocio I R Macias; Chiara Raggi; Maria J Perugorria; Eugenio Gaudio; Kirsten M Boberg; Jose J G Marin; Domenico Alvaro
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-04-20       Impact factor: 46.802

8.  Unveiling the role of tumor reactive stroma in cholangiocarcinoma: an opportunity for new therapeutic strategies.

Authors:  Massimiliano Cadamuro; Stuart Duncan Morton; Mario Strazzabosco; Luca Fabris
Journal:  Transl Gastrointest Cancer       Date:  2013-07

9.  Risk Stratification of Cholangiocarcinoma Patients Presenting with Jaundice: A Retrospective Analysis from a Tertiary Referral Center.

Authors:  Ana Lleo; Francesca Colapietro; Patrick Maisonneuve; Monia Aloise; Vincenzo Craviotto; Roberto Ceriani; Lorenza Rimassa; Salvatore Badalamenti; Matteo Donadon; Vittorio Pedicini; Alessandro Repici; Luca Di Tommaso; Antonio Voza; Guido Torzilli; Alessio Aghemo
Journal:  Cancers (Basel)       Date:  2021-04-25       Impact factor: 6.639

Review 10.  Liquid biopsy in cholangiocarcinoma: Current status and future perspectives.

Authors:  Gianluca Rompianesi; Marcello Di Martino; Alex Gordon-Weeks; Roberto Montalti; Roberto Troisi
Journal:  World J Gastrointest Oncol       Date:  2021-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.